Cargando…

Possible Alternate Explanation for Cases of Idiopathic Pulmonary Fibrosis

Detalles Bibliográficos
Autor principal:	Frank, Arthur L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169122/ https://www.ncbi.nlm.nih.gov/pubmed/35289726 http://dx.doi.org/10.1513/AnnalsATS.202202-139LE

Ejemplares similares

Reply: Possible Alternate Explanation for Cases of Idiopathic Pulmonary Fibrosis
por: Kaul, Bhavika, et al.
Publicado: (2022)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries
por: Mooney, Joshua, et al.
Publicado: (2019)

Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation
por: Maher, Toby M., et al.
Publicado: (2019)

How many patients with idiopathic pulmonary fibrosis are there in Brazil?
por: Baddini-Martinez, José, et al.
Publicado: (2015)

Economic consequences of idiopathic pulmonary fibrosis in Denmark
por: Hilberg, Ole, et al.
Publicado: (2018)

Genetic overlap between idiopathic pulmonary fibrosis and COVID−19
por: Allen, Richard J, et al.
Publicado: (2022)

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison
por: Papiris, Spyros A., et al.
Publicado: (2019)

Monocyte as a prognostic marker in patients with idiopathic pulmonary fibrosis
por: Zhu, Shiping
Publicado: (2021)

The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B
por: Zhang, Qinghua, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic
por: Faverio, P., et al.
Publicado: (2023)

Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient
por: Raamsteeboers, Aniek J., et al.
Publicado: (2014)

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis
por: Molyneaux, Philip L., et al.
Publicado: (2017)

Reflux in idiopathic pulmonary fibrosis: treatment informed by an integrated approach
por: Jones, Rhys, et al.
Publicado: (2018)

Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis
por: DeDent, Alison M., et al.
Publicado: (2022)

The Systematic Removal of Participants Post-Randomization Can Lead to Alternate Explanations of the Results
por: Cunningham, John A
Publicado: (2013)

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis
por: de Brouwer, Bart, et al.
Publicado: (2018)

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience
por: Mullerpattan, Jai B, et al.
Publicado: (2019)

The world is not enough – the value of increasing registry data in idiopathic pulmonary fibrosis
por: Moor, C. C., et al.
Publicado: (2020)

Thoracic ultrasound: Possible complementary criteria for the assessment of pulmonary fibrosis
por: Trovato, Guglielmo M., et al.
Publicado: (2014)

COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib
por: Caradec, E., et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Alternative explanations of the Eötvös results
por: Fischbach, E, et al.
Publicado: (1986)

Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Hachisu, Yoshimasa, et al.
Publicado: (2019)

GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis
por: Gobbo, Francesca, et al.
Publicado: (2023)

An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition
por: Mishra, Amartya, et al.
Publicado: (2011)

Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Letter]
por: Orsatti, Leticia, et al.
Publicado: (2019)

Electrocardiographic ST-segment elevation with prominent R waves in precordial leads—an alternative explanation
por: Gorgels, A. P. M.
Publicado: (2022)

Hydrating the respiratory tract: An alternative explanation why masks lower severity of COVID-19
por: Courtney, Joseph M., et al.
Publicado: (2021)

Cough in Idiopathic Pulmonary Fibrosis
por: Mann, Jennifer, et al.
Publicado: (2021)

Explanation of Criminality
por: Line, Maurice B.
Publicado: (1962)

Active transcription in the vascular bed characterizes rapid progression in idiopathic pulmonary fibrosis
por: Sharma, Nirmal S., et al.
Publicado: (2023)

Fatal thrombocytopenia: A rare case with possible explanation
por: Barik, Ramachandra, et al.
Publicado: (2012)

Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis
por: Oldham, Justin M., et al.
Publicado: (2023)

A rare case of perinephric urinoma due to idiopathic retroperitoneal fibrosis
por: Cha, Jin Joo, et al.
Publicado: (2009)

No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis
por: Le Hingrat, Quentin, et al.
Publicado: (2020)

An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis
por: Fernández Pérez, Evans R., et al.
Publicado: (2018)

A possible explanation for resistance in schizophrenia
por: Emna, B., et al.
Publicado: (2022)

A Possible Explanation for Holes in the Stack
por: Keil, Eberhard
Publicado: (1973)

Cannot write session to /tmp/vufind_sessions/sess_p5hol2jdaivs55fb07790p48oh